|
Due
to its clinical, patient and practice benefits, the Optomap
retinal exam has the potential to become part of the standard
of care in practices throughout the world. In addition to its many clinical and patient benefits,
the Optomap also allows doctors to spend more time with patients, and provides a permanent
photo-documentation that can be sent to a patient’s primary care physician or specialist if
needed and can also be used to educate patients.
Various
studies have concluded that the Optomap exam, is effective in
increasing the quality of a clinical evaluation of the retina
in a primary eye care setting; is a reliable tool for the
detection of retinal disease; and has sensitivity similar to
the current gold standard - clinical evaluation through a
dilated pupil. This
study also concluded that the Optomap exam detected three
times more retinal abnormalities than a clinical evaluation
through an undilated pupil. A separate study sponsored by the American Optometric
Association in 2000 showed that 52% of patients presenting for
an eye exam are NOT dilated.
More
About
Optos
The
Optos modality was developed as a patient-friendly examination
tool by Douglas Anderson, founder and vice chairman, Optos,
after his son Leif lost the use of an eye when a retinal
detachment was detected too late. It incorporates the
latest in scanning laser ophthalmoscope (SLO) technology,
using low-powered red-green laser beams to capture an image of virtually the
entire retina on an "Optomap", a permanent digital
record that gives clinicians a view of the retina that is
unprecedented with prior technologies.
To find out more about the Optomap Exam – visit www.optomap.com
|